Headquarters
200 POWDER MILL RD BLDG 500, WILMINGTON, DE 19803-2907, US
WILMINGTON, DE, US
CELLERGY PHARMA INC.
From the company
Cellergy Pharma is a privately held biotechnology company founded in 2022 that develops novel CAR T cell products for treating severe atopic allergic diseases. Its patented EMPD and FcεRI chimeric antigen receptors target the cells that produce immunoglobulin E, the cause of all atopic allergic diseases. The company aims to move CAR T cells beyond cancer treatment to diseases caused by the immune system, with a mission to cure severe allergic diseases including uncontrollable severe allergic asthma and severe food allergy.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.